Title
Category
Credits
Event date
Cost
  • Health equity
  • 1.50 AAFP - Family Physicians
  • 1.50 ACPE - Pharmacists
  • 1.50 ACPE - Pharmacy Technicians
  • 1.50 AMA - Physicians
  • 1.50 ANCC - Nurses
  • 1.50 APA - Psychologists
  • 1.50 Attendance - General Attendance
  • 1.50 CCMC - General - Case Managers
  • 1.50 COPE - Optometrists
  • 1.50 ASWB - Social Workers
$0.00
This activity will raise awareness of the identities and experiences of the LGBTQ+ community, as well as ways to address the unique health-related disparities affecting the community. It will discuss appropriate use of pronouns and terminology and review current statistics regarding social and health care disparities experienced by this community. Lastly, it will explore how to create environments in which LGBTQ+ individuals can feel validated, safe, and welcome. 
  • Health equity
  • 1.00 AAFP - Family Physicians
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 COPE - Optometrists
  • 1.00 ASWB - Social Workers
$0.00
This activity will provide health care providers with increased awareness surrounding these issues so that communication with LGBTQ+ people is respectful and sensitive. It will review how patient-provider interactions can be more supportive of the individual’s needs, how to take a full history and perform an inclusive and affirming physical exam, and how health information can be thoughtfully documented to provide accurate information regarding health issues, screening recommendations and risk prevention.
  • Disease management
  • Vision
  • 1.00 Attendance - General Attendance
  • 1.00 COPE - Optometrists
$0.00
This activity will examine risk factors for glaucoma that will assist health care professionals (HCPs) in the early identification of this condition in general primary eye care practice. Individual risk factors will be discussed, and pertinent literature will be reviewed to provide insight into how certain factors in combination, such as Krukenberg spindles, homogeneous trabecular meshwork pigmentation and iris transillumination defects can indicate an increased risk and alert HCPs to the presence of this disorder. A new tool will be introduced to help recommend when specific glaucoma testing is indicated.
  • Disease management
  • Vision
  • 1.00 Attendance - General Attendance
  • 1.00 COPE - Optometrists
$0.00
Ocular Anterior Surface Disease or dry eye syndrome affects nearly 16 million Americans and can be a common and chronic problem for adults, especially for those of advanced age, causing symptoms that interfere with eye comfort, function and quality of life. Competent evaluation to determine the etiology of dry eye syndrome is necessary for successful symptom management as therapeutic regimens must be specific to the underlying causes to be effective. This activity will examine the multiple parts of eye anatomy, the dysfunction of which may contribute to dry eye syndrome, including the tear film, ocular anterior surface and Meibomian gland, and identify complications that can result when dry eye is left untreated. Importantly, a thorough review of optimal treatment regimens will be provided, as well as updates on newer and emerging targeted treatments, with a focus on providing relief and preventing further damage to the eye.
  • Disease management
  • Vision
  • 1.00 Attendance - General Attendance
  • 1.00 COPE - Optometrists
$0.00
Diabetes can cause potentially irreparable eye damage and poor vision over time. This activity will review the role of optometrists in the areas of prevention, co-management and rehabilitation for individuals with diabetes. It will focus on how to conduct a diabetes risk assessment, ongoing care of individuals with known diabetes and collaboration among members of the interprofessional health care team for optimal outcomes. Key strategies for vision rehabilitation will also be addressed.
  • Vision
  • 1.00 Attendance - General Attendance
  • 1.00 COPE - Optometrists
$0.00
Age-related macular degeneration (ARMD) affects roughly 11 million people in the US and is the leading cause of visual impairment for older individuals. Its severe and rapid impact on vision requires vigilant prevention and screening practices, as well as a thorough understanding of diagnostic procedures and the optimal use of current and emerging therapies. This activity will provide an overview of the multiple subtypes of ARMD, including dry, intermediate, and wet ARMD, and geographic atrophy. It will explore existing and emerging therapies for ARMD subtypes, as well as their efficacy and safety profiles. In addition, testing strategies that can help determine the direction of ARMD management plans, as well as applications and programs for low-vision care, will be identified.
  • Disease management
  • Vision
  • 1.00 Attendance - General Attendance
  • 1.00 COPE - Optometrists
$0.00
This activity will focus on the evaluation and management of oculomotor symptoms associated with acquired brain injuries (ABI) due to concussion, stroke and other causes. It will discuss the battery of tests that can establish the presence of oculomotor dysfunction and will cover available treatment options, including glasses, prism glasses, therapeutic eye drops and vision therapy. The importance of a team management approach through collaboration and referrals will be stressed. After this activity, eye doctors should be comfortable evaluating patients with a history of concussion or ABI.
  • Disease management
  • Vision
  • 1.00 AMA - Physicians
  • 1.00 Attendance - General Attendance
  • 1.00 COPE - Optometrists
$0.00
This activity will explore updated approaches to the management of glaucoma—the “silent thief of sight” that affects an estimated 3 million Americans. It will examine the latest evidence from recent studies on minimally invasive glaucoma surgery (MIGS) procedures and discuss comparative data on more invasive surgical techniques such as trabeculectomy and tube shunt surgery. Patient cases will be introduced to enhance participants’ understanding of the glaucoma treatment process. In addition, potential future innovations in glaucoma treatment will be discussed.
  • Disease management
  • Vision
  • 1.00 AMA - Physicians
  • 1.00 Attendance - General Attendance
  • 1.00 COPE - Optometrists
$0.00
This activity will provide a current update to participants’ comprehensive knowledge and understanding of various contact lens options for patients with common diagnoses requiring medically necessary contact lenses. This session will delve into the tool chest of contact lens solutions, including standard rigid gas permeable (RGP) lens designs, reverse geometry RGPs, hybrids and scleral lenses. Participants will explore the anatomy of contact lenses, specific designs and applications for conditions such as keratoconus and irregular corneas. The activity will also cover the advantages and considerations associated with each lens type, patient experiences and advancements in scleral lens designs.
  • Intellectual and developmental disabilities
  • 2.00 ACPE - Pharmacists
  • 2.00 ACPE - Pharmacy Technicians
  • 2.00 AMA - Physicians
  • 2.00 ANCC - Nurses
  • 2.00 APA - Psychologists
  • 2.00 Attendance - General Attendance
  • 2.00 CCMC - General - Case Managers
  • 2.00 CDR - Dietitians
  • 2.00 COPE - Optometrists
  • 2.00 ASWB - Social Workers
$0.00
This activity will provide learners with an overview of clinical considerations in adults with IDD and improve communication skills and practices that can better guide treatment choices to address the specific needs of these individuals. Learners will take a closer look at existing bias, stigma and discrimination toward these individuals and learn strategies to address these issues in practice. Lastly, the value of improved interprofessional team collaboration between health care professionals (HCPs), caregivers and direct support professionals will be discussed.

Pages